PELVIC INFLAMMATORY DISEASE (PID)

PELVIC INFLAMMATORY DISEASE (PID),
SEXUALLY TRANSMITTED

Wisconsin Division of Public Health Disease Surveillance Manual (EpiNet, January 2001)

I.     IDENTIFICATION

A.     CLINICAL DESCRIPTION: A spectrum of inflammatory disorders of the female upper genital tract. Sexually transmitted organisms, especially N. gonorrhoeae and C. trachomatis, are implicated in most cases, however, other endogenous organisms such as anaerobes, gram negative rods, streptococci and mycoplasmas may also be the etiologic agents of disease.

B.     REPORTING CRITERIA: Laboratory confirmed by isolation of organisms listed above or by clinical diagnosis.
C.    WISCONSIN CASE DEFINITION: Laboratory confirmed infection via culture or by laparoscopic findings consistent with PID.

II.     ACTIONS REQUIRED

A.     WISCONSIN DISEASE SURVEILLANCE CATEGORY II: REPORT TO THE LOCAL HEALTH DEPARTMENT within 72 hours of the identification of a case or suspected case. Limited public health intervention is expected (except in cases of N. gonorrhoeae and C. trachomatis, LHD staff should refer to those sections of this manual for follow-up) see section C below for details.

B.     EPIDEMIOLOGY REPORT FORMS REQUESTED:

Sexually Transmitted Disease Morbidity and Epidemiologic Case Report (DPH 4243), OR

Acute and Communicable Diseases Case Report (DPH 4151 )

C.     PUBLIC HEALTH INTERVENTION:

LHD investigation and sex partner referral only for PID cases where N. gonorrhoeae and/or C. trachomatis have been identified. LHD staff should refer to those sections of this manual for further information.

LHD staff should assure that appropriate treatment was administered and documented on report form.

LHD staff should also assure clinical follow-up has taken place within 72 hours of starting appropriate antibiotic treatment.

III.     CONTACTS FOR CONSULTATION

A.    DPH REGIONAL STAFF: No regional office staff assigned to STD.
B.    DPH, BUREAU OF COMMUNICABLE DISEASES, STD CONTROL SECTION:

(608) 266-7365 (Madison) or (414) 286-5526 (Milwaukee).

C.     WSLH / BACTERIOLOGY: (608) 262-1616.
D.    MILWAUKEE BUREAU OF LABORATORIES: (414) 286-3526.

IV.     PREVENTION MEASURES

A.     Patients treated for PID should be counseled regarding their risk for other sexually transmitted diseases including HIV.

B.     Treatment: Successful treatment cures infection, resolves clinical symptoms and prevents transmission to others. In extensive cases, scarring may result despite successful therapy. Patient can be referred to an infertility specialist. One episode may pre-dispose women to subsequent PID episodes.

V.     RELATED REFERENCES

1.     Sexually Transmitted Disease Treatment Guidelines. MMWR 1998; 47(RR-1): 79-86.

2.     Sexually Transmitted Disease Clinical Practice Guidelines, 1991, CDC.
3.    Wisconsin Administrative Code, Chapter HFS 145, 1997, No. 498.
VI.    DISEASE TRENDS

Data not available.

	Sexually Transmitted Disease Morbidity and Epidemiologic Case Report (DPH 4243), OR
	Acute and Communicable Diseases Case Report (DPH 4151 )

	LHD investigation and sex partner referral only for PID cases where N. gonorrhoeae and/or C. trachomatis have been identified. LHD staff should refer to those sections of this manual for further information.
	LHD staff should assure that appropriate treatment was administered and documented on report form.
	LHD staff should also assure clinical follow-up has taken place within 72 hours of starting appropriate antibiotic treatment.